This Research Topic is part of the series Cervical Cancer Awareness:
Volume I - Screening, Vaccines and PreventionCervical Cancer Awareness Month takes place every January. Cervical cancer is the fourth most common cancer among women, despite it being both preventable and curable if detected early and managed well.
Due to increased screening and prevention, the impact of this cancer has been greatly reduced. However, global inequities in prevention result in limited access to health services including prophylactic HPV vaccinations, and screening and treatment of precancerous cervical cancer lesions, have led to disproportionately high morbidity and mortality in low and middle-income countries.
Any individual with a uterine cervix is at risk for cervical cancer but most cervical cancer occurs in women over the age of 30 years. At least half of sexually active people will have HPV at some point in their lives but only a few women will get cervical cancer.
Cervical cancer impacts women in many ways including but not limited to psychological, physical and social health impacts. Disability and deaths from cervical cancer impose disease burdens on women and their families thereby contributing to significant reduction in quality of life.
This occasion not only offers an opportunity to raise awareness of the importance of cervical cancer screening and HPV vaccination but also hopes to contribute to the elimination of cervical cancer worldwide in line with the World Health Organisation cervical cancer elimination strategy.
This research topic aims to cover, but is not limited to:
• Access to screening and prevention strategies in low- and middle-income countries
• Quality of life in the context of cervical cancer diagnosis (importance of diagnosis, support and care, treatment and therapies)
• Psychological and quality of life impacts related to cervical cancer (including interpersonal relationships, physical health impacts, and lived experience of cervical cancer)
• Economic consequences and impacts related to cervical cancer
• Experiences with cervical cancer- related services and healthcare professionals
We welcome Case reports, Commentary, Case series, Cross- sectional studies, Controlled Trials, Original Research and Reviews.
